abagovomab 36
abciximab 37
abituzumab 17
abrilumab 21
actoxumab 28
adalimumab 9
aducanumab 11
afasevikumab 7
alacizumab_pegol 6
alemtuzumab 40
alirocumab 14
amatuximab 46
andecaliximab 25
anifrolumab 28
anrukinzumab 15
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 20
ascrinvacumab 16
atezolizumab 10
atinumab 17
avelumab 16
basiliximab 37
bavituximab 31
begelomab 26
benralizumab 25
bevacizumab_beta 16
bezlotoxumab 28
bimagrumab 24
bleselumab 28
blinatumomab 33
blosozumab 33
bococizumab 31
brazikumab 17
brentuximab_vedotin 30
briakinumab 15
brodalumab 22
brolucizumab 20
brontictuzumab 30
burosumab 30
cabiralizumab 26
camrelizumab 14
canakinumab 19
cantuzumab_ravtansin 45
carlumab 21
carotuximab 12
cergutuzumab_amunaleukin2 34
cergutuzumab_amunaleukin 34
certolizumab_pegol 22
cetiximab 33
citatuzumab_bogatox 25
cixutumumab 40
clivatuzumab_tetraxetan 29
codrituzumab 29
conatumumab 21
concizumab 17
crenezumab 19
crizanlizumab 28
crotedumab 22
dacetuzumab 23
daclizumab 25
dalotuzumab 34
dapirolizumab_pegol 25
daratumumab 13
dectrekumab 9
demcizumab 33
denosumab 10
depatuxizumab 31
depatuxizumab_mafodotin 31
dezamizumab 25
dinutuximab 34
diridavumab 31
domagrozumab 15
drozitumab 18
duligotuzumab 20
durvalumab 13
dusigitumab 35
efalizumab 37
efungumab 24
eldelumab 17
elezanumab 39
elgemtumab 8
elotuzumab 16
emactuzumab 28
emapalumab 20
emibetuzumab 23
enavatuzumab 27
enfortumab_vedotin 12
enoblituzumab 18
enokizumab 34
enoticumab 21
ensituximab 33
eptinezumab 10
erenumab 28
etaracizumab 12
etrolizumab 24
evinacumab 21
evolocumab 24
farletuzumab 0
fasinumab 34
fezakinumab 27
fibatuzumab 23
ficlatuzumab 33
firivumab 32
flanvotumab 23
fletikumab 41
foralumab 15
foravirumab 15
fremanezumab 24
fresolimumab 19
fulranumab 16
futuximab 26
galcanezumab 21
ganitumab 31
gantenerumab 16
gemetuzumab 36
gemtuzumab2 33
gemtuzumab 19
gevokizumab 28
girentuximab 29
glembatumumab 26
glembatumumab_vedotin 26
guselkumab 32
ibalizumab 25
ibritumomab 36
icrucumab 15
idarucizumab 32
ifabotuzumab 23
imalumab 14
imgatuzumab 32
inclacumab 16
indatuximab_ravtansin 35
indusatumab 21
inebilizumab 27
intetumumab 13
iodine_girentuximab 25
ipilimumab 4
iratumumab 23
isatuximab 32
itolizumab 21
ixekizumab 27
labetuzumab_govitecan 29
lambrolizumab 31
lampalizumab 29
lanadelumab 19
landogrozumab 20
laprituximab 26
lebrikizumab 31
lendalizumab 34
lenzilumab 26
lifastuzumab_vedotin 20
ligelizumab 24
lilotomab 36
lirilumab 30
lodelcizumab 29
lokivetmab 12
lorvotuzumab_mertansin 18
lucatumumab 30
lumretuzumab 27
lupartumab 16
lutikizumab 12
margetuximab 32
milatuzumab 26
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 48
mogamulizumab 21
monalizumab 26
motavizumab 31
moxetumomab_pasudotox 14
namilumab 27
naratuximab 37
naratuximab_emtansin 37
narnatumab 16
navicixizumab2 32
navicixizumab 33
navivumab 24
necitumumab 23
nemolizumab 39
nesvacumab 16
nivolumab 17
obiltoxaximab 20
obinutuzumab 34
ocaratuzumab 25
ofatumumab 14
olaratumab 26
olokizumab 25
omalizumab 20
onartuzumab 24
ontuxizumab 20
opicinumab 17
orticumab 10
otelixizumab 27
oxelumab 8
ozanezumab 25
pamrevlumab 7
panobacumab 23
parsatuzumab 30
pasotuxizumab 18
pateclizumab 17
patritumab 31
pembrolizumab 31
perakizumab 24
pidilizumab 19
pinatuzumab_vedotin 17
plozalizumab 16
pogalizumab 31
polatuzumab_vedotin 20
ponezumab 35
prezalumab 14
pritoxaximab 35
quilizumab 16
racotumomab 30
radretumab 11
ralpancizumab 34
ramucirumab 13
ranevetmab 30
ranibizumab 13
refanezumab 18
remtolumab 10
rilotumumab 28
rinucumab 21
risankizumab 37
rituximab 23
rivabazumab 23
robatumumab 21
roledumab 17
romosozumab 25
rontalizumab 26
rosmantuzumab 29
rozanolixizumab 18
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 31
sapelizumab 23
sarilumab 11
secukinumab 19
seribantumab 19
setoxaximab 42
sifalimumab 18
siltuximab 12
simtuzumab 34
sirukumab 10
solanezumab 32
solitomab 30
stamulumab 28
suptavumab 25
suvizumab 23
tabalumab 17
tadocizumab 24
tamtuvetmab 37
tanezumab 28
tarextumab 10
tavolixizumab 17
telisotuzumab 31
teplizumab 20
tesidolumab 31
tezepelumab 29
tigatuzumab 13
tildrakizumab 30
timolumab 13
tisotumab 13
tosatoxumab 36
tositumomab 33
tralokinumab 37
trastuzumab 26
tregalizumab 19
trevogrumab 8
ublituximab 35
urelumab 29
ustekinumab 28
utomilumab 28
vadastuximab 25
vadastuximab_talirin 25
vandortuzumab_vedotin 21
vantictumab 25
vanucizumab2 16
vanucizumab 34
varlilumab 18
vatelizumab 28
vedolizumab 27
veltuzumab 27
vesencumab 10
vorsetuzumab 29
vorsetuzumab_mafodotin 29
vunakizumab 33
xentuzumab 18
zatuximab 48
